Investigating bacterial penetration of the blood-brain barrier for the pathogenesis, prevention and therapy of bacterial meningitis.
The most distressing aspect of bacterial meningitis is limited improvement in the mortality and morbidity attributable to advances in antimicrobial chemotherapy and supportive care. . A major contributing factor to such mortality and morbidity is in our incomplete understanding of the pathogenesis of this disease. Microbial penetration of the blood-brain barrier, a prerequisite for the development of bacterial meningitis, exploits specific host and bacterial factors as well as host cell signaling molecules. Determination and characterization of such host and bacterial factors has been instrumental for developing our current knowledge on the pathogenesis of bacterial meningitis. In addition, counteracting such host and microbial factors is shown to be efficacious in prevention of bacterial meningitis. Antimicrobial therapy alone has limited efficacy in improving the outcome of bacterial meningitis. Recent studies suggest that counteracting targets contributing to bacterial penetration of the blood-brain barrier is a beneficial therapeutic adjunct to antimicrobial therapy in improving the outcome of bacterial meningitis. Taken together, these findings indicate that elucidation of host and bacterial factors contributing to microbial penetration of the blood-brain barrier provides a novel strategy for investigating the pathogenesis, prevention and therapy of bacterial meningitis.